BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30083255)

  • 41. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
    Du Y; Shi A; Han B; Li S; Wu D; Jia H; Zheng C; Ren L; Fan Z
    Int J Oncol; 2014 Apr; 44(4):1385-93. PubMed ID: 24535190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases.
    Yun EJ; Song KS; Shin S; Kim S; Heo JY; Kweon GR; Wu T; Park JI; Lim K
    Oncotarget; 2016 Aug; 7(31):49961-49971. PubMed ID: 27363023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An in vitro hyaluronic acid hydrogel based platform to model dormancy in brain metastatic breast cancer cells.
    Narkhede AA; Crenshaw JH; Crossman DK; Shevde LA; Rao SS
    Acta Biomater; 2020 Apr; 107():65-77. PubMed ID: 32119920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation.
    Hsu JY; Chang KY; Chen SH; Lee CT; Chang ST; Cheng HC; Chang WC; Chen BK
    Oncotarget; 2015 Jan; 6(3):1723-39. PubMed ID: 25595899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. STC1 expression is associated with tumor growth and metastasis in breast cancer.
    Chang AC; Doherty J; Huschtscha LI; Redvers R; Restall C; Reddel RR; Anderson RL
    Clin Exp Metastasis; 2015 Jan; 32(1):15-27. PubMed ID: 25391215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells.
    Stasinopoulos I; O'Brien DR; Wildes F; Glunde K; Bhujwalla ZM
    Mol Cancer Res; 2007 May; 5(5):435-42. PubMed ID: 17510310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
    Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
    Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer.
    Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
    Anat Rec (Hoboken); 2010 Nov; 293(11):1838-46. PubMed ID: 20830783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
    Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases.
    Smakman N; Kranenburg O; Vogten JM; Bloemendaal AL; van Diest P; Borel Rinkes IH
    Clin Cancer Res; 2005 Jan; 11(1):41-8. PubMed ID: 15671526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
    Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
    Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression.
    Park SY; Jin ML; Kim YH; Lee SJ; Park G
    Oncol Rep; 2014 Jan; 31(1):497-504. PubMed ID: 24220687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in NO- and PGI
    Buczek E; Denslow A; Mateuszuk L; Proniewski B; Wojcik T; Sitek B; Fedorowicz A; Jasztal A; Kus E; Chmura-Skirlinska A; Gurbiel R; Wietrzyk J; Chlopicki S
    BMC Cancer; 2018 May; 18(1):582. PubMed ID: 29788918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis.
    Chaturvedi P; Gilkes DM; Wong CC; ; Luo W; Zhang H; Wei H; Takano N; Schito L; Levchenko A; Semenza GL
    J Clin Invest; 2013 Jan; 123(1):189-205. PubMed ID: 23318994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway.
    Tang X; Jin R; Qu G; Wang X; Li Z; Yuan Z; Zhao C; Siwko S; Shi T; Wang P; Xiao J; Liu M; Luo J
    Cancer Res; 2013 Oct; 73(20):6206-18. PubMed ID: 24008316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteomic characterization of early lung response to breast cancer metastasis in mice.
    Kurpińska A; Suraj J; Bonar E; Zakrzewska A; Stojak M; Sternak M; Jasztal A; Walczak M
    Exp Mol Pathol; 2019 Apr; 107():129-140. PubMed ID: 30763573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancer.
    Wu K; Fukuda K; Xing F; Zhang Y; Sharma S; Liu Y; Chan MD; Zhou X; Qasem SA; Pochampally R; Mo YY; Watabe K
    J Biol Chem; 2015 Apr; 290(15):9842-54. PubMed ID: 25691572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis.
    Kozaki K; Koshikawa K; Tatematsu Y; Miyaishi O; Saito H; Hida T; Osada H; Takahashi T
    Oncogene; 2001 Jul; 20(31):4228-34. PubMed ID: 11464289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
    Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
    Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
    Trapp EK; Majunke L; Zill B; Sommer H; Andergassen U; Koch J; Harbeck N; Mahner S; Friedl TWP; Janni W; Rack B; Alunni-Fabbroni M
    Mol Oncol; 2017 Nov; 11(11):1508-1526. PubMed ID: 28700115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.